QA: Synaptogenix Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001571934_2023_Synaptogenix_Inc.pdf

Logs

Graph

Absolute values for 0001571934, Synaptogenix Inc.

  xvar xval
0 AssetsCurrent 38,585,661
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 22,145
3 remainder_Assets 0
4 LiabilitiesCurrent 1,312,810
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,880,300
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,810,068
9 ResearchAndDevelopmentExpense 6,324,928
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 10,561,039
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 38,607,806
1 Liabilities 3,193,110
2 Expenses 16,134,996
3 Revenues 0
4 StockholdersEquity 35,414,696
5 NetIncome -5,573,957
6 ComprehensiveNetIncome -5,573,957
7 BaseVar 34,248,476
8 EconomicCapitalRatio 2.65

Edgar->Model Mapping

Feature Distribution

Change over Time